VTYX Stock Price History and Quote Analysis: Insights for Investors

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own VTYX shares is 160, representing 91.61% of the company's common stock.

DIMENSIONAL FUND ADVISORS LP, in the last quarter, reduced its stake in VTYX by -29.45% restricting it's holding to 12.01 thousand shares of worth nearly $66.06K. STATE STREET CORP also lessened -6.45% of the VTYX shares from its portfolio, reducing its holding to 926.59 thousand shares of worth $5.10M. MILLENNIUM MANAGEMENT LLC also shunned VTYX shares holding by -75.57% last quarter which brought its holding to 472.67 thousand shares worth $2.60M.

As per its latest 13F filing, CITADEL ADVISORS LLC increased its stake in VTYX by 38.09% in the last quarter. The institutional holder raised its holding to 5.89 million shares having worth more than $31.80M. MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. also added 100% more shares of VTYX to its portfolio, raising its holding to 13.17 thousand shares of worth $403.55K. SIMPLEX TRADING, LLC also increased its VTYX shares holding by 7.77% which brought its holding to 13.04 thousand shares worth $71.00K.

The insider with the most stakes in VTYX is NSV Partners III LP , 10 percent owner at the company. Additionally, VTYX stock is highly held by Subramaniam Somu and CEO AND PRESIDENT Mohan Raju among others.

Company executives, directors, and other insiders own 3.31% percent of Ventyx Biosciences, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which VTYX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include NUSS JOHN, AUSTER MARTIN, and MOHAN RAJU.

There have been 0 transaction(s) during the past 6-months in which Ventyx Biosciences, Inc. insiders have bought stock, totalling 0 shares

Around 0 Ventyx Biosciences, Inc. shares are held by insiders, which represents about 3.31% of VTYX stock.

VTYX 10 percent owner, NSV Partners III LP holds the largest portfolio of the company's shares. VTYX shares owned by NSV total nearly 8.44 million.

CITADEL ADVISORS LLC is the largest institutional owner in VTYX which holds 5.89 million shares worth $31.80M or 9.97% of the total VTYX shares outstanding followed by MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. with ownership of 13.17 thousand shares representing 0.02% of the VTYX ownership. SIMPLEX TRADING, LLC is the third largest stakeholder with 13.04 thousand shares or 0.02% of the ownership worth more than $71.00K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the VTYX is concerned, it is a stock which is optionable.

Number of VTYX shares short is 8.38M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 70.67M shares of VTYX are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, VTYX has 49.68M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for VTYX is 5.56.